Nonetheless, accumulated studies indicate that serum MMP-9 may be a novel therapeutic target and biomarker for depression (55–57, 60–63), although a cautionary note is that blood level of MMP-9 may not directly correlate with brain MMP-9 content. This evidence concerns the gene MMP9 and major depressive disorder.